𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Efficacy and safety of long-acting risperidone in stable patients with schizoaffective disorder

✍ Scribed by Robert Lasser; Cynthia A. Bossie; Georges Gharabawi; Marielle Eerdekens; Henry A. Nasrallah

Book ID
113665218
Publisher
Elsevier Science
Year
2004
Tongue
English
Weight
443 KB
Volume
83
Category
Article
ISSN
0165-0327

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of long-acting rispe
Efficacy and safety of long-acting risperidone in elderly patients with schizophrenia and schizoaffective disorder
✍ Robert A. Lasser; Cynthia A. Bossie; Young Zhu; Georges Gharabawi; Mariëlle Eerd 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB 👁 2 views

## Abstract ## Background Elderly patients are often an underserved population in terms of optimizing treatment outcomes. Long‐acting risperidone, the first long‐acting injectable atypical antipsychotic, can improve outcomes through continuous medication delivery. ## Objective To assess the effi

Long-term safety and efficacy of long-ac
Long-term safety and efficacy of long-acting risperidone in elderly psychotic patients
✍ Werner Kissling; Per Glue; Rossella Medori; Steve Simpson 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB 👁 1 views

## Abstract This subgroup analysis of the 6‐month, open‐label Switch to Risperidone Microspheres (StoRMi) trial evaluated long‐term safety and efficacy of a direct conversion to risperidone long‐acting injectable (RLAI) in 52 elderly patients (≥65 years) with psychosis stabilized on oral or depot a